Mint Tower Capital Management B.V. Clovis Oncology, Inc. Call Options Transaction History

Mint Tower Capital Management B.V.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 13, 2020	SELL	$3.77 - $11.0 $18,850 - $55,000	-5,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $88,300 - $151,400	5,000 New	5,000 $2,000
Q3 2018 Nov 06, 2018	SELL	$29.37 - $49.48 $146,850 - $247,399	-5,000 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$42.06 - $62.4 $210,300 - $312,000	5,000 New	5,000 $227,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

Stay updated on Mint Tower Capital Management B.V. with notifications on news.